Does baseline proteinuria affect the efficacy of obinutuzumab in patients with primary membranous nephropathy and minimal change disease? a single-center retrospective study

Xueting Li, Yinghui Zhang, Ben Ke

Open source

DOI
10.3389/fphar.2026.1912188
Published
2026-09-09
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1912188,
  title = {Does baseline proteinuria affect the efficacy of obinutuzumab in patients with primary membranous nephropathy and minimal change disease? a single-center retrospective study},
  author = {Xueting Li and Yinghui Zhang and Ben Ke},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1912188},
  url = {https://doi.org/10.3389/fphar.2026.1912188}
}

RIS

TY  - JOUR
TI  - Does baseline proteinuria affect the efficacy of obinutuzumab in patients with primary membranous nephropathy and minimal change disease? a single-center retrospective study
AU  - Xueting Li
AU  - Yinghui Zhang
AU  - Ben Ke
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1912188
UR  - https://doi.org/10.3389/fphar.2026.1912188
ER  - 

APA

Li, X., Zhang, Y., & Ke, B. (2026). Does baseline proteinuria affect the efficacy of obinutuzumab in patients with primary membranous nephropathy and minimal change disease? a single-center retrospective study. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1912188

Source records